Conference on Analgesic Trials
The cost for APS CAT is $100. Preregistration is required.
As a follow up to 2016’s first annual APS Conference on Analgesic Trials (APS-CAT), APS will present the second annual APS-CAT on May 17, 2017. This event will be chaired and moderated by Neil Singla, MD, APS Clinical Trials special interest group chair and chief scientific officer of Lotus Clinical Research.
APS-CAT is a full-day conference focused on optimizing the design and conduct of analgesic clinical trials. APS-CAT 2016 had 200 pain research professionals in attendance and featured expert presentations as well as Q & A with an eight-member panel. Audience feedback was overwhelmingly positive.
APS-CAT 2017 presenters include
Lars Arendt-Nielsen, MD PhD
Center for Sensory-Motor Interaction (SMI)
Department of Health Science and Technology, School of Medicine, Aalborg University
Translational, Quantitative, Healthy Volunteer Pain Models of Pain and Sensitization
Laurie Burke, MD
Founder, LORA Group
Former Director, FDA Study Endpoints and Labeling Development (SEALD) Team
Getting the Claims You Want: Optimizing Your Study Endpoints and Labeling
Sharon Hertz, MD
Director, FDA Division of Anesthesia, Analgesia, and Addiction Products
Nathaniel Katz, MD
President, Analgesic Solutions
What Can Be Done About the Placebo Response in Clinical Trials: A Review of the Evidence
Bob Rappaport, MD
Founder, Analgesic Concepts
Former Director, FDA Division of Anesthesia, Analgesia, and Addiction Products
Getting the Indication You Want: Selecting an Appropriate Analgesic Model
Lee Simon, MD
Principal, SDG, LLC
Former Director, FDA Division of Analgesic, Anti-Inflammatory and Ophthalmologic Drug Products
Clinical Trial Design Considerations for Studies in Osteoarthritis
Neil Singla, MD
Chief Scientific Officer, Lotus Clinical Research
Opioid Sparing Endpoints: Trial Design, Clinical Relevance and Label Claims
APS-CAT features a panel format, with each presenter speaking for 30 minutes followed by 30 minutes of audience/panel Q & A.
The goals of this conference are:
- Gather world-renowned experts in clinical trials to convey and analyze current best practices.
- Disseminate the latest scientific and regulatory developments in topics of interest to the analgesic research industry.
- Discuss experimental methods that increase analgesic trial assay sensitivity.
- Involve audience members in dialogue with thought leaders in the field from regulatory bodies, industry, and academia.
- Convene at a familiar venue before the APS Annual Scientific Meeting to facilitate networking and future collaboration.
For questions or comments, please contact Clinical Trials SIG Chair Neil Singla, MD.